These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 12844484

  • 1. Mitochondrial complex I is deficient in renal oncocytomas.
    Simonnet H, Demont J, Pfeiffer K, Guenaneche L, Bouvier R, Brandt U, Schagger H, Godinot C.
    Carcinogenesis; 2003 Sep; 24(9):1461-6. PubMed ID: 12844484
    [Abstract] [Full Text] [Related]

  • 2. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma.
    Gasparre G, Hervouet E, de Laplanche E, Demont J, Pennisi LF, Colombel M, Mège-Lechevallier F, Scoazec JY, Bonora E, Smeets R, Smeitink J, Lazar V, Lespinasse J, Giraud S, Godinot C, Romeo G, Simonnet H.
    Hum Mol Genet; 2008 Apr 01; 17(7):986-95. PubMed ID: 18156159
    [Abstract] [Full Text] [Related]

  • 3. Loss of complex I due to mitochondrial DNA mutations in renal oncocytoma.
    Mayr JA, Meierhofer D, Zimmermann F, Feichtinger R, Kögler C, Ratschek M, Schmeller N, Sperl W, Kofler B.
    Clin Cancer Res; 2008 Apr 15; 14(8):2270-5. PubMed ID: 18413815
    [Abstract] [Full Text] [Related]

  • 4. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.
    Ugalde C, Janssen RJ, van den Heuvel LP, Smeitink JA, Nijtmans LG.
    Hum Mol Genet; 2004 Mar 15; 13(6):659-67. PubMed ID: 14749350
    [Abstract] [Full Text] [Related]

  • 5. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III.
    Bonora E, Porcelli AM, Gasparre G, Biondi A, Ghelli A, Carelli V, Baracca A, Tallini G, Martinuzzi A, Lenaz G, Rugolo M, Romeo G.
    Cancer Res; 2006 Jun 15; 66(12):6087-96. PubMed ID: 16778181
    [Abstract] [Full Text] [Related]

  • 6. Human mitochondrial complex I deficiency: investigating transcriptional responses by microarray.
    van der Westhuizen FH, van den Heuvel LP, Smeets R, Veltman JA, Pfundt R, van Kessel AG, Ursing BM, Smeitink JA.
    Neuropediatrics; 2003 Feb 15; 34(1):14-22. PubMed ID: 12690563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Defective mitochondrial ATP synthesis in oxyphilic thyroid tumors.
    Savagner F, Franc B, Guyetant S, Rodien P, Reynier P, Malthiery Y.
    J Clin Endocrinol Metab; 2001 Oct 15; 86(10):4920-5. PubMed ID: 11600563
    [Abstract] [Full Text] [Related]

  • 9. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma.
    Simonnet H, Alazard N, Pfeiffer K, Gallou C, Béroud C, Demont J, Bouvier R, Schägger H, Godinot C.
    Carcinogenesis; 2002 May 15; 23(5):759-68. PubMed ID: 12016148
    [Abstract] [Full Text] [Related]

  • 10. Mitochondria with tubulovesicular cristae in renal oncocytomas.
    Bárcena C, Martínez MA, Ortega MP, Muñoz HG, Sárraga GU.
    Ultrastruct Pathol; 2010 Dec 15; 34(6):315-20. PubMed ID: 21070162
    [Abstract] [Full Text] [Related]

  • 11. Respiratory chain complex I is a mitochondrial tumor suppressor of oncocytic tumors.
    Zimmermann FA, Mayr JA, Feichtinger R, Neureiter D, Lechner R, Koegler C, Ratschek M, Rusmir H, Sargsyan K, Sperl W, Kofler B.
    Front Biosci (Elite Ed); 2011 Jan 01; 3(1):315-25. PubMed ID: 21196312
    [Abstract] [Full Text] [Related]

  • 12. Respiratory chain complex I deficiency.
    Triepels RH, Van Den Heuvel LP, Trijbels JM, Smeitink JA.
    Am J Med Genet; 2001 Jan 01; 106(1):37-45. PubMed ID: 11579423
    [Abstract] [Full Text] [Related]

  • 13. Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.
    Xiao Y, Clima R, Busch J, Rabien A, Kilic E, Villegas SL, Timmermann B, Attimonelli M, Jung K, Meierhofer D.
    Cancer Res; 2020 Sep 15; 80(18):3830-3840. PubMed ID: 32694149
    [Abstract] [Full Text] [Related]

  • 14. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul 15; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 15. Renal oncocytoma. I. Cytochrome c oxidase in normal and neoplastic renal tissue as detected by immunohistochemistry--a valuable aid to distinguish oncocytomas from renal cell carcinomas.
    Ortmann M, Vierbuchen M, Koller G, Fischer R.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988 Jul 15; 56(3):165-73. PubMed ID: 2906189
    [Abstract] [Full Text] [Related]

  • 16. Genetic defects in the oxidative phosphorylation (OXPHOS) system.
    Janssen RJ, van den Heuvel LP, Smeitink JA.
    Expert Rev Mol Diagn; 2004 Mar 15; 4(2):143-56. PubMed ID: 14995902
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of mitochondrial biogenesis and paradoxical inhibition of lactate dehydrogenase mediated by 14-3-3η in oncocytomas.
    Feng J, Zhang Q, Li C, Zhou Y, Zhao S, Hong L, Song Q, Yu S, Hu C, Wang H, Mao C, Shepard MJ, Hao S, Dominah G, Sun M, Wan H, Park DM, Gilbert MR, Xu G, Zhuang Z, Zhang Y.
    J Pathol; 2018 Jul 15; 245(3):361-372. PubMed ID: 29704241
    [Abstract] [Full Text] [Related]

  • 18. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.
    Maurer IC, Schippel P, Volz HP.
    Bipolar Disord; 2009 Aug 15; 11(5):515-22. PubMed ID: 19624390
    [Abstract] [Full Text] [Related]

  • 19. Mitochondria and reactive oxygen species in renal cancer.
    Hervouet E, Simonnet H, Godinot C.
    Biochimie; 2007 Sep 15; 89(9):1080-8. PubMed ID: 17466430
    [Abstract] [Full Text] [Related]

  • 20. Control of OXPHOS efficiency by complex I in brain mitochondria.
    Cocco T, Pacelli C, Sgobbo P, Villani G.
    Neurobiol Aging; 2009 Apr 15; 30(4):622-9. PubMed ID: 17875347
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.